Identification of 1-(thiophene-2-carbonyl)-LSD from blotter paper falsely labeled "1D-LSD".
Yuki Okada, Kazuki Ueno, Noriko Nishiwaki, Toshihiko Nishimura, Hiroki Segawa, Tadashi Yamamuro, Kenji Kuwayama, Kenji Tsujikawa, Tatsuyuki Kanamori, Yuko T Iwata
Forensic toxicology January 1, 2024 DOI: 10.1007/s11419-023-00668-8 via PubMed
Summary
AI-generated from the abstractBlotter paper labeled "1D-LSD" was seized and analyzed. Although the label suggested the compound was 1-(1,2-dimethylcyclobutane-1-carbonyl)-LSD, chemical analysis using GC/MS, LC/MS, high-resolution mass spectrometry, and NMR spectroscopy revealed the actual substance to be 1-(thiophene-2-carbonyl)-LSD, a different lysergamide. This is the first reported seizure of this compound and the first LSD analog where an aromatic carboxylic acid was condensed to LSD. The finding highlights that drug-infused blotter paper may contain substances inconsistent with their labeling, and authorities should remain vigilant for newly emerging lysergamides.
Study at a glance
| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 3 |
| Population | Three pieces of blotter paper |
| Topics | LSD |
| Keywords | High-resolution mass spectrometry Lysergamide New psychoactive substances Drug analysis |
| Citations | 8 |
| Key finding | The seized blotter paper labeled "1D-LSD" actually contained 1-(thiophene-2-carbonyl)-LSD, not the expected compound. |
Abstract
Since the mid-2010s, lysergic acid diethylamide (LSD) analogs made for substance abuse have periodically emerged. In this case, three pieces of blotter paper labeled "1D-LSD" and presumably impregnated with this LSD analog, were seized. Several websites indicate that 1D-LSD is 1-(1,2-dimethylcyclobutane-1-carbonyl)-LSD. Because this analog is much more difficult to synthesize than previously reported LSD analogs, we doubted that the blotter paper contained 1D-LSD. Herein, we determined the structure of the absorbed compound. One of the seized specimens was extracted and analyzed using gas chromatography/mass spectrometry (GC/MS), liquid chromatography/mass spectrometry (LC/MS), high-resolution mass spectrometry (HRMS), and nuclear magnetic resonance (NMR) spectroscopy to estimate the extract components. The estimated compound was then synthesized, yielding an authentic standard. The contents of the seized specimens were identified using authentic standard analysis with GC/MS, LC/MS, and NMR spectroscopy. Instrumental analyses confirmed the active compound to be 1-(thiophene-2-carbonyl)-LSD, which was inconsistent with the labeling on drug-infused blotter paper. As in this case, similar blotter paper analyses should consider the possibility of a mismatch between the label and ingredient. To the authors' knowledge, this is the first case report in which 1-(thiophene-2-carbonyl)-LSD was seized and the first seizure of an LSD analog in which an aromatic carboxylic acid had been condensed to LSD. This type of lysergamide may become prevalent in the near future, and we should remain alert for newly appearing lysergamides.